Germany approves Novartis' Celtura

Novartis AG (NYSE:NVS; SIX:NOVN) said the German regulatory authorities approved Celtura, an MF59-adjuvanted cell culture-based swine influenza A (H1N1) vaccine. The pharma said it continues to pursue...